Eintrag weiter verarbeiten
| author_facet |
Bieber, T. Cork, M. Reitamo, S. Bieber, T. Cork, M. Reitamo, S. |
|---|---|
| author |
Bieber, T. Cork, M. Reitamo, S. |
| spellingShingle |
Bieber, T. Cork, M. Reitamo, S. Allergy Atopic dermatitis: a candidate for disease‐modifying strategy Immunology Immunology and Allergy |
| author_sort |
bieber, t. |
| spelling |
Bieber, T. Cork, M. Reitamo, S. 0105-4538 1398-9995 Wiley Immunology Immunology and Allergy http://dx.doi.org/10.1111/j.1398-9995.2012.02845.x <jats:title>Abstract</jats:title><jats:p>The concept of disease modification has been introduced to define the therapeutic strategies aimed to break, stop, or reverse the natural course of a chronic invalidating disease. This strategy is tightly related to the biomarker‐based stratification of affected patients using genetic and other biological markers. With regard to the progress in understanding the genetic background of atopic dermatitis (<jats:styled-content style="fixed-case">AD</jats:styled-content>), its natural history and its pivotal role in the emergence of allergic asthma, the time is mature to foster the research field of biomarkers in <jats:styled-content style="fixed-case">AD</jats:styled-content> and to consider the elaboration of disease‐modifying strategies in the management of <jats:styled-content style="fixed-case">AD</jats:styled-content> with the goal to stop or even reverse the atopic march.</jats:p> Atopic dermatitis: a candidate for disease‐modifying strategy Allergy |
| doi_str_mv |
10.1111/j.1398-9995.2012.02845.x |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzOTgtOTk5NS4yMDEyLjAyODQ1Lng |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzOTgtOTk5NS4yMDEyLjAyODQ1Lng |
| institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 |
| imprint |
Wiley, 2012 |
| imprint_str_mv |
Wiley, 2012 |
| issn |
0105-4538 1398-9995 |
| issn_str_mv |
0105-4538 1398-9995 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
bieber2012atopicdermatitisacandidatefordiseasemodifyingstrategy |
| publishDateSort |
2012 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Allergy |
| source_id |
49 |
| title |
Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_unstemmed |
Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_full |
Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_fullStr |
Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_full_unstemmed |
Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_short |
Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_sort |
atopic dermatitis: a candidate for disease‐modifying strategy |
| topic |
Immunology Immunology and Allergy |
| url |
http://dx.doi.org/10.1111/j.1398-9995.2012.02845.x |
| publishDate |
2012 |
| physical |
969-975 |
| description |
<jats:title>Abstract</jats:title><jats:p>The concept of disease modification has been introduced to define the therapeutic strategies aimed to break, stop, or reverse the natural course of a chronic invalidating disease. This strategy is tightly related to the biomarker‐based stratification of affected patients using genetic and other biological markers. With regard to the progress in understanding the genetic background of atopic dermatitis (<jats:styled-content style="fixed-case">AD</jats:styled-content>), its natural history and its pivotal role in the emergence of allergic asthma, the time is mature to foster the research field of biomarkers in <jats:styled-content style="fixed-case">AD</jats:styled-content> and to consider the elaboration of disease‐modifying strategies in the management of <jats:styled-content style="fixed-case">AD</jats:styled-content> with the goal to stop or even reverse the atopic march.</jats:p> |
| container_issue |
8 |
| container_start_page |
969 |
| container_title |
Allergy |
| container_volume |
67 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792348186762805254 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T18:07:11.732Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Atopic+dermatitis%3A+a+candidate+for+disease%E2%80%90modifying+strategy&rft.date=2012-08-01&genre=article&issn=1398-9995&volume=67&issue=8&spage=969&epage=975&pages=969-975&jtitle=Allergy&atitle=Atopic+dermatitis%3A+a+candidate+for+disease%E2%80%90modifying+strategy&aulast=Reitamo&aufirst=S.&rft_id=info%3Adoi%2F10.1111%2Fj.1398-9995.2012.02845.x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792348186762805254 |
| author | Bieber, T., Cork, M., Reitamo, S. |
| author_facet | Bieber, T., Cork, M., Reitamo, S., Bieber, T., Cork, M., Reitamo, S. |
| author_sort | bieber, t. |
| container_issue | 8 |
| container_start_page | 969 |
| container_title | Allergy |
| container_volume | 67 |
| description | <jats:title>Abstract</jats:title><jats:p>The concept of disease modification has been introduced to define the therapeutic strategies aimed to break, stop, or reverse the natural course of a chronic invalidating disease. This strategy is tightly related to the biomarker‐based stratification of affected patients using genetic and other biological markers. With regard to the progress in understanding the genetic background of atopic dermatitis (<jats:styled-content style="fixed-case">AD</jats:styled-content>), its natural history and its pivotal role in the emergence of allergic asthma, the time is mature to foster the research field of biomarkers in <jats:styled-content style="fixed-case">AD</jats:styled-content> and to consider the elaboration of disease‐modifying strategies in the management of <jats:styled-content style="fixed-case">AD</jats:styled-content> with the goal to stop or even reverse the atopic march.</jats:p> |
| doi_str_mv | 10.1111/j.1398-9995.2012.02845.x |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzOTgtOTk5NS4yMDEyLjAyODQ1Lng |
| imprint | Wiley, 2012 |
| imprint_str_mv | Wiley, 2012 |
| institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1 |
| issn | 0105-4538, 1398-9995 |
| issn_str_mv | 0105-4538, 1398-9995 |
| language | English |
| last_indexed | 2024-03-01T18:07:11.732Z |
| match_str | bieber2012atopicdermatitisacandidatefordiseasemodifyingstrategy |
| mega_collection | Wiley (CrossRef) |
| physical | 969-975 |
| publishDate | 2012 |
| publishDateSort | 2012 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Allergy |
| source_id | 49 |
| spelling | Bieber, T. Cork, M. Reitamo, S. 0105-4538 1398-9995 Wiley Immunology Immunology and Allergy http://dx.doi.org/10.1111/j.1398-9995.2012.02845.x <jats:title>Abstract</jats:title><jats:p>The concept of disease modification has been introduced to define the therapeutic strategies aimed to break, stop, or reverse the natural course of a chronic invalidating disease. This strategy is tightly related to the biomarker‐based stratification of affected patients using genetic and other biological markers. With regard to the progress in understanding the genetic background of atopic dermatitis (<jats:styled-content style="fixed-case">AD</jats:styled-content>), its natural history and its pivotal role in the emergence of allergic asthma, the time is mature to foster the research field of biomarkers in <jats:styled-content style="fixed-case">AD</jats:styled-content> and to consider the elaboration of disease‐modifying strategies in the management of <jats:styled-content style="fixed-case">AD</jats:styled-content> with the goal to stop or even reverse the atopic march.</jats:p> Atopic dermatitis: a candidate for disease‐modifying strategy Allergy |
| spellingShingle | Bieber, T., Cork, M., Reitamo, S., Allergy, Atopic dermatitis: a candidate for disease‐modifying strategy, Immunology, Immunology and Allergy |
| title | Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_full | Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_fullStr | Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_full_unstemmed | Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_short | Atopic dermatitis: a candidate for disease‐modifying strategy |
| title_sort | atopic dermatitis: a candidate for disease‐modifying strategy |
| title_unstemmed | Atopic dermatitis: a candidate for disease‐modifying strategy |
| topic | Immunology, Immunology and Allergy |
| url | http://dx.doi.org/10.1111/j.1398-9995.2012.02845.x |